Pulmonx Corp
LUNG1.695USD
+0.085+5.28%
Market hours （ET）Quotes delayed by 15 min
69.06MMarket Cap
LossP/E TTM
More Details of Pulmonx Corp Company
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.
Company Info
Ticker SymbolLUNG
Company namePulmonx Corp
IPO dateOct 01, 2020
CEOMr. Steven S. (Steve) Williamson
Number of employees291
Security typeOrdinary Share
Fiscal year-endOct 01
Address700 Chesapeake Dr
CityREDWOOD CITY
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94063
Phone16509342600
Websitehttps://pulmonx.com/
Ticker SymbolLUNG
IPO dateOct 01, 2020
CEOMr. Steven S. (Steve) Williamson
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey Beran Rose
Mr. Geoffrey Beran Rose
Chief Commercial Officer
Chief Commercial Officer
237.06K
-2.85%
Mr. Daniel P. (Dan) Florin
Mr. Daniel P. (Dan) Florin
Independent Director
Independent Director
102.02K
+145.58%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Independent Director
Independent Director
71.81K
+68.35%
Ms. Tiffany Sullivan
Ms. Tiffany Sullivan
Independent Director
Independent Director
59.98K
+162.74%
Mr. Thomas William Burns
Mr. Thomas William Burns
Independent Director
Independent Director
58.18K
+176.67%
Mr. Steven S. (Steve) Williamson
Mr. Steven S. (Steve) Williamson
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
30.45K
-24.58%
Mr. Mehul Joshi
Mr. Mehul Joshi
Chief Financial Officer
Chief Financial Officer
11.52K
-41.16%
Mr. Brian Johnston
Mr. Brian Johnston
Investor Relations
Investor Relations
--
--
Mr. David A. Lehman
Mr. David A. Lehman
General Counsel
General Counsel
--
--
Ms. Georgia Garinoismelenikiotou
Ms. Georgia Garinoismelenikiotou
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Geoffrey Beran Rose
Mr. Geoffrey Beran Rose
Chief Commercial Officer
Chief Commercial Officer
237.06K
-2.85%
Mr. Daniel P. (Dan) Florin
Mr. Daniel P. (Dan) Florin
Independent Director
Independent Director
102.02K
+145.58%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Independent Director
Independent Director
71.81K
+68.35%
Ms. Tiffany Sullivan
Ms. Tiffany Sullivan
Independent Director
Independent Director
59.98K
+162.74%
Mr. Thomas William Burns
Mr. Thomas William Burns
Independent Director
Independent Director
58.18K
+176.67%
Mr. Steven S. (Steve) Williamson
Mr. Steven S. (Steve) Williamson
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
30.45K
-24.58%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
14.22M
63.10%
Europe, Middle-East and Africa ("EMEA")
5.48M
24.33%
Asia Pacific
2.79M
12.40%
Other International
38.00K
0.17%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
PRIMECAP Management Company
13.45%
Fidelity Management & Research Company LLC
11.71%
Morgan Stanley & Co. LLC
7.27%
BlackRock Institutional Trust Company, N.A.
6.30%
The Vanguard Group, Inc.
5.67%
Other
55.60%
Shareholders
Shareholders
Proportion
PRIMECAP Management Company
13.45%
Fidelity Management & Research Company LLC
11.71%
Morgan Stanley & Co. LLC
7.27%
BlackRock Institutional Trust Company, N.A.
6.30%
The Vanguard Group, Inc.
5.67%
Other
55.60%
Shareholder Types
Shareholders
Proportion
Investment Advisor
51.20%
Hedge Fund
16.03%
Investment Advisor/Hedge Fund
14.74%
Research Firm
9.33%
Individual Investor
4.21%
Sovereign Wealth Fund
0.38%
Bank and Trust
0.19%
Pension Fund
0.05%
Insurance Company
0.03%
Other
3.85%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
286
39.72M
98.66%
-2.86M
2025Q1
296
39.33M
97.70%
-4.34M
2024Q4
300
39.10M
98.27%
-6.73M
2024Q3
306
39.39M
100.59%
-8.60M
2024Q2
305
38.59M
99.39%
-11.14M
2024Q1
300
38.64M
99.54%
-10.45M
2023Q4
294
37.11M
96.84%
-10.90M
2023Q3
296
35.84M
94.15%
-16.29M
2023Q2
300
36.45M
96.58%
-16.49M
2023Q1
313
37.10M
98.35%
-13.03M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
PRIMECAP Management Company
5.41M
13.45%
-97.53K
-1.77%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.71M
11.71%
-443.86K
-8.61%
Mar 31, 2025
Morgan Stanley & Co. LLC
2.93M
7.27%
+396.76K
+15.68%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.54M
6.3%
-38.08K
-1.48%
Mar 31, 2025
The Vanguard Group, Inc.
2.28M
5.67%
-1.15K
-0.05%
Mar 31, 2025
Deerfield Management Company, L.P.
1.89M
4.69%
+355.24K
+23.15%
Mar 31, 2025
BNP Paribas Asset Management USA, Inc.
1.25M
3.11%
--
--
Mar 31, 2025
DWS Investments UK Limited
1.13M
2.81%
+31.06K
+2.82%
Mar 31, 2025
Silvercrest Asset Management Group LLC
930.56K
2.31%
+930.56K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
927.54K
2.3%
+25.30K
+2.80%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Proshares Ultra Russell 2000
0%
Avantis US Equity ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Broad Market ETF
0%
FlexShares Morningstar US Market Factor Tilt Index Fund
0%
Goldman Sachs Innovate Equity ETF
0%
SPDR S&P Health Care Equipment ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0%
Avantis US Equity ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proportion0%
Goldman Sachs Innovate Equity ETF
Proportion0%
SPDR S&P Health Care Equipment ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
